Wegovy-maker Novo Nordisk raises outlook as sales of its weight-loss drug soar
A selection of injector pens for the Saxenda weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. Jim Vondruska | Reuters Novo Nordisk, which makes the weight-loss drug Wegovy, raised its outlook for 2023 Thursday, as it reported soaring sales. The Danish pharmaceutical company reported a 30% increase…
Read More “Wegovy-maker Novo Nordisk raises outlook as sales of its weight-loss drug soar” »